对人类TMPRSS2的单克隆抗体可以防止任何SARS-CoV-2变种的感染
Michishige Harada1, Takehisa Matsumoto2, Mizuki Yamamoto3
1Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
iScience
|December 15, 2025
概括
针对跨膜血清蛋白酶2 (TMPRSS2) 的单克隆抗体有效地阻断了SARS-CoV-2的进入和复制在体外和体内. 这些TMPRSS2抗体为抗击COVID-19变种提供了有前途的治疗策略.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 跨膜血清蛋白酶2 (TMPRSS2) 对于SARS-CoV-2尖端蛋白原始化至关重要,促进病毒进入宿主细胞.
- TMPRSS2是COVID-19治疗的验证治疗标.
研究的目的:
- 开发和评估针对人类TMPRSS2的单克隆抗体 (mAbs),用于针对SARS-CoV-2的治疗应用.
- 评估TMPRSS2 mAbs在抑制SARS-CoV-2感染中的疗效,在体外和体内.
主要方法:
- 对人类TMPRSS的单克隆抗体的建立2.
- 使用SARS-CoV-2感染细胞系和人类肺器官的mAb疗效的体外评估.
- 在人体ACE2/TMPRSS2-双重敲进小鼠和模型中的体内评估.
主要成果:
- 在包括Omicron在内的所有测试变种中,TMPRSS2 mAbs证明了对SARS-CoV-2感染的强有力的抑制.
- mAbs的向性表位与活性部位不同,这表明它在不抑制蛋白酶活性的情况下对S蛋白-ACE2/TMPRSS2相互作用进行了固体阻断.
- 在体内研究表明,在接受治疗的动物中,病毒标位的显著抑制和肺炎的减少.
结论:
- 针对TMPRSS2的单克隆抗体是SARS-CoV-2感染的有效抑制剂.
- 这些针对TMPRSS2的mAbs代表了管理COVID-19的有希望的治疗途径,包括新兴变种感染.
相关概念视频
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


